Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir plus Ribavirin in Japanese patients with Genotype 2 HCV
NCT01910636Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir in chronic hepatitis C genotype 2, sponsored by Gilead Sciences. Started Feb 2013; status: completed.
02
Drugs
sofosbuvir
03
Conditions
chronic hepatitis C genotype 2
Beyond the preview
Go deeper on NCT01910636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910636.